New Immunotherapy Target for Ovarian Cancer

Translate to Spanish or other 102 languages!

Because ovarian cancer has limited symptoms, it can go undetected until it has spread. At a later stage, it becomes challenging to treat and has had limited success from existing immunotherapies and checkpoint inhibitors. Image for illustration purposes
Because ovarian cancer has limited symptoms, it can go undetected until it has spread. At a later stage, it becomes challenging to treat and has had limited success from existing immunotherapies and checkpoint inhibitors. Image for illustration purposes
- Advertisement -

By Mayo Clinic

Newswise — ROCHESTER, Minn. — Mayo Clinic researchers have discovered a new immunotherapy target, a cryptic antigen, may be key in helping the immune system fight tumors in ovarian cancer. The study, published in Science Advances, could improve treatment approaches for this type of cancer.

Because ovarian cancer has limited symptoms, it can go undetected until it has spread. At a later stage, it becomes challenging to treat and has had limited success from existing immunotherapies and checkpoint inhibitors.

- Advertisement -

Cryptic antigens are part of a protein — known as epitopes — that are usually hidden or inaccessible to the immune system and may be present in tumor cells. By targeting these antigens, the immune system can be effectively mobilized to attack the cancer.

“These findings underscore the need to look at alternate sources of target antigens for ovarian cancer,” says Marion R. Curtis, Ph.D., senior author of the study and immunologist at Mayo Clinic Comprehensive Cancer Center. “Discovering tumor-associated antigens that T cells recognize is crucial for the success of immunotherapeutic approaches in ovarian cancer, where the growth of cells that form in the ovaries multiply quickly and can invade and destroy healthy body tissue.”

T cells are a critical component of the adaptive immune system. Their ability to recognize and respond to specific targets is fundamental to their function. They play a significant role in developing and treating cancer and are vital in the immune system’s fight against infections.

In this study, the researchers characterized tumor antigens generated from ovarian cancer using multi-omics approaches to determine their ability to trigger an immune response. Multi-omics encompasses using multiple “omes” (i.e., genome, proteome, microbiome, epigenome) to better understand the mechanisms of disease processes, detection, potential prevention and more focused therapies.

- Advertisement -

Researchers have previously focused on discovering newly formed antigens (neoantigens). However, a previous study revealed that neoantigens are rarely found in ovarian cancer samples, making them unattractive targets.

The next steps involve preclinical testing and clinical trials to evaluate the safety and efficacy of new immunotherapies and vaccines that target these cryptic antigens. The researchers also plan larger-scale studies to determine the prevalence of cryptic antigen expression across various tumor types, potentially paving the way for broader applications of this immunotherapy approach.

Review the study for a complete list of authors, disclosures and funding.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Mayo Clinic Study Sheds New Light on Memory Loss

A new framework, published in Brain, could reshape researchers' understanding of how the brain creates memories and experiences, and how disruptions in this process may indicate Alzheimer’s disease and other forms of dementia.

United States and Mexico Lose Measles Elimination Status Amid Continued Outbreaks

The United States, Mexico and Bolivia have lost their measles elimination status after the highly contagious virus circulated continuously for more than 12 months, the Pan American Health Organization (PAHO) announced November 17, 2026.

Eating and sleeping later associated with increased health risks

Staying up late and eating later in the evening could increase the risk of metabolic syndrome, a term that refers to conditions that increase the risk of type 2 diabetes, cardiovascular disease, and high cholesterol.

Health Officials Release Joint Statement Regarding Loss of U.S. Measles Elimination Status

CDC and its partners are committed to stopping measles outbreaks, protecting Americans, and regaining measles elimination status.
- Advertisement -